Advanced Course - BHRT Practical Clinical Applications
Course Cost – $795.00
Courses are Enduring Materials from a Clinical Applications for Age Management Medicine Conference
So, you have attended lectures, talked to colleagues and studied the literature. Now you are ready to jump into the fray of actually wanting to implement BHRT into your clinical practice. This course will provide you with very practical and concise information to be able to properly evaluate your patients and determine the best course of action to balance or replace the much-needed hormones: testosterone, estradiol, progesterone. This is a nuts and bolts series providing understanding on laboratory interpretation and optimal levels, pros and cons of different hormone delivery systems, how to properly dose each system and the knowledge to properly manage inevitable complications of BHRT. Lastly, you will be given a basic framework of best practices in protecting your license while practicing in the area of hormonal medicine.
* In conjunction with the Hormonal Health Institute
Course Prerequisite
Completion of the Online Education Course Clinical Use of Hormones in Age Management Medicine Part 2, (cost is included). This prerequisite offers basic information that is critical to understanding this advanced course.
Course Access: After purchasing this course you will receive an email with your unique username and password to access the prerequisite Clinical Use of Hormones in Age Management Medicine Part 2.
NOTE: If you have already purchased and completed the prerequisite please contact us at admin@agemed.org.
Curriculum
FACULTY
- Founder, Hormonal Health Institute
- Medical Director, Belmar Pharm Solutions
- CEO & Founder, DrM Integrative Health
Dr. Angela DeRosa, DO, MBA, CPE, is a dynamic professional on a mission to change the face of women’s health and wellness. As a respected, internationally recognized authority on women’s hormonal health, Dr. DeRosa understands the range of health issues women face leading up to and during menopause as she herself was in full-blown menopause by the age of 35. Dr. DeRosa has more than 25 years experience in the medical field, both on the pharmaceutical side and in clinical practice. In 2006 she founded DeRosa Medical, which quickly became eponymous with bio-identical hormonal healthcare. She eventually sold her company in the fall 2017 to Houston-based, Nobilis Health in order to focus on new opportunities.
Dr. DeRosa’s enthusiasm for educating patients on the realities of menopause and the risk factors hormonal health imbalances has never waned. It was the driving force behind her first bestselling book, How Your Doctor Is Slowly Killing You: A Woman’s Health Survival Guide. Her book, along with its controversial title, caught the attention of the public, media and the medial community. In fact, she received an avalanche of requests from physicians across the country wanting to learn more. In 2018, she heeded their call by launching The Hormonal Health Institute: Executive Instruction for Medical Professionals, a hormonal healthcare consultancy designed to instruct medial providers and provide practice development training on bio-identical hormonal replacement therapies.
Dr. DeRosa is a member of the International Menopause Society, European Andropause and Menopause Society, International Society of the Study of Women’s Sexual Health and a researcher on women’s health issues. Dr. DeRosa is Clinical Assistant Professor at Midwestern University, Arizona College of Osteopathic Medicine, Clinical Assistant Professor of the Department of Internal Medicine at the University of Arizona College of Medicine – Phoenix, and is the Immediate Past President of the Arizona Osteopathic Medical Association.
FACULTY DISCLOSURE: No Relevant Relationships with a Commercial Interest to Disclose
- Physician, Re-new Institute, Omaha, NE
- Medical Director, Metro Men’s Health, National
Dr. Melissa Loseke is a family medicine physician who’s passion is innovative medicine. Dr. Loseke practiced primary care for 18 months before turning her focus to regenerative and functional medicine. She joined a clinic specializing in treating chronic joint pain with Hyaluronic Acid injections, Platelet Rich Plasma (PRP), and Stem Cell therapies. With the constant desire to learn and for cutting edge treatments for her patients, she began to practice at a nationwide hormone replacement organization specializing in pellet therapy for hormone replacement as well as aesthetics. During her tenure there, Dr. Loseke expanded her scope of certifications to include the Vampire Facelift, Vampire Breastlift, O shot, and Priapus Shot, as well as Low-Level Laser Therapy, or photobiomodulation, used to treat various injuries and chronic conditions. After four years of service, she then took a role as Chief Medical Officer for a national testosterone replacement company and Medical Director of a partner female hormone replacement clinic. During that time, she expanded her knowledge as part of the inaugural A4M Peptide Certification group. Dr Loseke, recently entered into private practice with the quest for a better way in medicine, with pillars of innovation, education and an experience unlike any other. Dr. Loseke constantly recommits herself to learning about the latest methods and treatments to help patients lead healthier lives, focusing on wellness not illness in treatment of patients. She has a passion for knowledge and educating, both patients and peers. One of her favorite sayings sums up the belief on the importance of not only balancing hormones but their vital role in overall health and well being, “Our hormone levels don’t decline because we age…Perhaps we age because our hormone levels decline.”
Course Information
Disclosure Statements
Conference Planning Committee – Disclosure
Mary L. Corry, R.N. – No Relevant Relationships with a Commercial Interest to Disclose
Mark L. Gordon, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Rob A. Kominiarek, D.O. – No Relevant Relationships with a Commercial Interest to Disclose
Cesar M. Pellerano, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
John Rush, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
George Shapiro, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Program Reviewers
Mary Corry, MSN and Dana Burnett, M. Ed. have no relevant financial relationships to disclose.
All relevant financial relationships for this event have been reviewed and mitigated.
Faculty Disclosures
Ardon Anderson, Ph.D. D. O. – No Relevant Relationships with a Commercial Interest to Disclose
Joseph E. Bosiljevac, J. R. M. D., Ph. D. – No Relevant Relationships with Commercial interest to Disclose
Katrina J. Breece, M. S. – No Relevant Relationships with Commercial Interest to Disclose
William Clearfield, D. O. – No Relevant Relationships with Commercial Interest to Disclose
Carolyn DeLucia, M. D. – No Relevant Relationships with Commercial Interest to Disclose
Elliot Dinetz, M. D. – No Relevant Relationships with Commercial Interest to Disclose
Angela DeRosa, D. O. – Belmar Pharmacy, Medical Director and Hormone Health Institute, Founder
Derrick DeSilva, Jr. M. D. – No Relevant Relationships with Commercial Interest to Disclose
Mark L. Gordon, M. D. – No Relevant Relationships with Commercial Interest to Disclose
Jay R. Hoffman, Ph.D. – Funding for Research Presented was funded in part by Carnosyn & Carnosyn Brand
Robert Kominiarek, D. O. – No Relevant Relationships with Commercial Interest to Disclose
Melissa Loseke Ablett, D. O. – No Relevant Relationships with Commercial Interest to Disclose
Luiz Martinez, M. D., MPH – No Relevant Relationships with Commercial Interest to Disclose
Steven Masley, M. D. – Author, The Mediterranean Method
Abraham Morgentaler, M. D. – Consultant, Acerus, Antares, Clarus, Advisory Committee Bayer, Research Grant Endo
Daniel Purser, M. D. – No Relevant Relationships with Commercial Interest to Disclose
George Shapiro, M. D. – No Relevant Relationships with Commercial Interest to Disclose
Betty Wedman-St. Louis, Ph. D. – No Relevant Relationships with Commercial Interest to Disclose
- Describe the essential scientific evidence-based information for the use of approved Hormones in Age Management Medicine and how to critically apply this knowledge to individualized treatment plans to improve patient outcomes.
- Describe and discuss issues which occur related to Hormone Therapy such as the use of Natural Aromatase Inhibitors effects of Testosterone on Prostate Cancer and Post Finasteride Syndrome.
- Describe evidence-based information for the diagnosis and treatment of Traumatic Brain Injury and how to clinically apply this knowledge to individualized patient treatment plans and summarize the available scientific literature discussing the primary traumas and secondary effects of inflammation in patient with TBI.
- Explain evidence-based information on Precision Medicine applications such as Epigenetic Methylation, Epigenetics and implications for Cardiovascular Disease, and Stem Cell Therapy for Immune System Restoration.
- Compare and discuss essential scientific evidence-based information on the use of Food and Medicine and various approaches to diet and nutrition in an effort to provide for superior patient outcomes.
- Discuss new scientific evidenced-based information for disease prevention and intervention, specifically for COVID-19 and how to clinically apply this knowledge to individualized patient treatment plans to improve patient outcomes.